Search results

92 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC co-leads large clinical trial on new combo therapy for type 2 diabetes
New insulin degludec has comparable cardiovascular safety rates to insulin glargine U100 but with less risk of triggering low blood sugar.
Located in News / 2017 / June
UNC researchers lead clinical trial evaluating potential treatment for postpartum depression
A phase 2, double-blind study of the investigational medication, brexanolone, in the treatment of women with severe PPD published in The Lancet. Clinical trials are currently underway at UNC.
Located in News / 2017 / June
Wake Forest Baptist, UNC Health Care Sign Binding Definitive Agreement Regarding Ownership of High Point Regional Health
Over the coming months, leadership from both Wake Forest Baptist and High Point Regional Health will be working together to take the necessary steps toward full integration.
Located in News / 2018 / March
The Measure of a Doctor
As Harold Pillsbury, MD, retires as chair of UNC Otolaryngology/ Head and Neck Surgery, we take a look back at his career through the eyes of one of his patients.
Located in News / 2018 / June
Predicting Autism: Study Links Infant Brain Connections to Diagnoses at Age 2
In two previous studies, University of North Carolina researchers and colleagues linked infant brain anatomy differences to autism diagnoses at age two. Now they show differences in functional connections between brain regions at 6 months to predict autism at age two.
Located in News / 2017 / June
Hormone therapy could effectively prevent depression for some women in the menopause transition
Research conducted by Susan Girdler, PhD, and David Rubinow, MD, and published in JAMA Psychiatry, is the first to conclude that a year of hormone therapy can effectively prevent the onset of depressive symptoms for women during the menopause transition.
Located in News / 2018 / January
Genetic Testing for Statin Therapy Not Cost-Effective
Research led by UNC School of Medicine MD/PhD student Jamie Jarmul, PhD, suggests physicians should defer to traditional 10-year risk score and existing statin guidelines in lieu of genetic tests.
Located in News / 2018 / May
Large Aggregates of ALS-causing Protein Might Actually Help Brain Cells
UNC School of Medicine scientists led by Nikolay Dokholyan, PhD, add to evidence that small aggregates of SOD1 protein are the brain-cell killing culprits in ALS, but the formation of larger, more visible, and fibril-like aggregates of the same protein may protect brain cells.
Located in News / 2018 / April
How blood vessels control their destiny
UNC researchers define the importance of the decoy receptor VEGFR1 in the process of angiogenesis, in findings that could have important implications in the treatment of cancer and other diseases.
Located in News / 2017 / June
Where Cigarette Smoking’s Damage is Done . . . Down to Your DNA
A new technique from UNC School of Medicine scientists led by Nobel Prize winner Aziz Sancar reveals the genome-wide DNA damage that a major carcinogen causes.
Located in News / 2017 / June